Marcelo Mendonça

Dr. Marcelo Mendonça

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2012 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
MMMarcelo Mendonça
Marcelo Mendonça
NCNeida L Conrad
Neida L Conrad
FCFabricio Conceição
Fabricio Conceição
ÂMÂngela N Moreira
Ângela N Moreira
WSWladimir Padilha da Silva
Wladimir Padilha da Silva
Arun K BhuniaArun K Bhunia
Arun K Bhunia
Background: Immunomagnetic separation (IMS) and immunoassays are widely used for pathogen detection. However, novel technology platforms with highly selective antibodies are essential to improve detection sensitivity, specificity and performance. In this study, monoclonal antibodies (MAbs) against Internalin A (InlA) and p30 were generated and used on paramagnetic beads of varying diameters for concentration, as well as on fiber-optic sensor for detection. Results: Anti-InlA MAb-2D12 (IgG2a subclass) was specific for Listeria monocytogenes and L. ivanovii, and p30-specific MAb-3F8 (IgM) was specific for the genus Listeria. At all bacterial concentrations (103–108 CFU/mL) tested in the IMS assay; the 1-μm diameter MyOne beads had significantly higher capture efficiency (P < 0.05) than the 2.8-μm diameter M-280 beads with both antibodies. The highest capture efficiency for MyOne-2D12 (49.2% for 105 CFU/mL) was significantly higher (P < 0.05) than that of MyOne-3F8 (16.6 %) and Dynabeads anti-Listeria antibody (9 %). Furthermore, capture efficiency for MyOne-2D12 was highly specific for L. monocytogenes and L. ivanovii. Subsequently, we captured L. monocytogenes by MyOne-2D12 and MyOne-3F8 from hotdogs inoculated with mono- or co-cultures of L. monocytogenes and L. innocua (10–40 CFU/g), enriched for 18 h and detected by fiber-optic sensor and confirmed by plating, light-scattering, and qPCR assays. The detection limit for L. monocytogenes and L. ivanovii by the fiber-optic immunosensor was 3 × 102 CFU/mL using MAb-2D12 as capture and reporter antibody. Selective media plating, light-scattering, and qPCR assays confirmed the IMS and fiber-optic results. Conclusions: IMS coupled with a fiber-optic sensor using anti-InlA MAb is highly specific for L. monocytogenes and L. ivanovii and enabled detection of these pathogens at low levels from buffer or food.

23 March 2016 in Scientific Reports
Verified
Journal Article
Open access
GMGustavo Marçal Schmidt Garcia Moreira
Gustavo Marçal Schmidt Garcia Moreira
Felipe Masiero SalvaraniFelipe Masiero Salvarani
Felipe Masiero Salvarani
CCCarlos Eduardo Pouey da Cunha
Carlos Eduardo Pouey da Cunha
MMMarcelo Mendonça
Marcelo Mendonça
ÂMÂngela Nunes Moreira
Ângela Nunes Moreira
FCFabricio Conceição
Fabricio Conceição
Clostridium perfringens is an anaerobic bacterium that produces several toxins. Of these, the alpha, beta, and epsilon toxins are responsible for causing the most severe C. perfringens-related diseases in farm animals. The best way to control these diseases is through vaccination. However, commercially available vaccines are based on inactivated toxins and have many production drawbacks, which can be overcome through the use of recombinant antigens. In this study, we produced recombinant alpha, beta, and epsilon toxins in Escherichia coli to formulate a trivalent vaccine. Its effectiveness was evaluated through a potency test in rabbits, in which the vaccine generated 9.6, 24.4, and 25.0 IU/mL of neutralizing antibodies against the respective toxins. Following this, cattle, sheep, and goats received the same formulation, generating, respectively, 5.19 ± 0.48, 4.34 ± 0.43, and 4.70 ± 0.58 IU/mL against alpha toxin, 13.71 ± 1.17 IU/mL (for all three species) against beta toxin, and 12.74 ± 1.70, 7.66 ± 1.69, and 8.91 ± 2.14 IU/mL against epsilon toxin. These levels were above the minimum recommended by international protocols. As such, our vaccine was effective in generating protective antibodies and, thus, may represent an interesting alternative for the prevention of C. perfringens-related intoxications in farm animals.

4 August 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MMMarcelo Mendonça
Marcelo Mendonça
GMGustavo Marçal Schmidt Garcia Moreira
Gustavo Marçal Schmidt Garcia Moreira
FCFabricio Rochedo Conceição
Fabricio Rochedo Conceição
MHMichael Hust
Michael Hust
KMKarla Sequeira Mendonça
Karla Sequeira Mendonça
JAJosé Antonio G. Aleixo
José Antonio G. Aleixo
Listeria monocytogenes is a ubiquitous food-borne pathogen, and its presence in food or production facilities highlights the importance of surveillance. Increased understanding of the surface exposed antigens on Listeria would provide potential diagnostic and therapeutic targets. In the present work, using mass spectrometry and genetic cloning, we show that fructose-1,6-bisphosphate aldolase (FBA) class II in Listeria species is the antigen target of the previously described mAb-3F8. Western and dot blot assays confirmed that the mAb-3F8 could distinguish all tested Listeria species from close-related bacteria. Localization studies indicated that FBA is present in every fraction of Listeria cells, including supernatant and the cell wall, setting Listeria spp. as one of the few bacteria described to have this protein on their cell surface. Epitope mapping using ORFeome display and a peptide membrane revealed a 14-amino acid peptide as the potential mAb-3F8 epitope. The target epitope in FBA allowed distinguishing Listeria spp. from closely-related bacteria, and was identified as part of the active site in the dimeric enzyme. However, its function in cell surface seems not to be host cell adhesion-related. Western and dot blot assays further demonstrated that mAb-3F8 together with anti-InlA mAb-2D12 could differentiate pathogenic from non-pathogenic Listeria isolated from artificially contaminated cheese. In summary, we report FBA as a novel immunogenic surface target useful for the detection of Listeria genus.

1 September 2003 in AIDS Patient Care and STDs
Verified
Journal Article
Closed access
JCJorge Casseb
Jorge Casseb
LFLuiz Augusto Marcondes Fonseca
Luiz Augusto Marcondes Fonseca
AVAna Paula Rocha Veiga
Ana Paula Rocha Veiga
AAAlexandre de Almeida
Alexandre de Almeida
ABAnalice Bueno
Analice Bueno
ADAlberto J.S. Duarte
Alberto J.S. Duarte
Brazilian AIDS and HIV-1-seropositive patients have had free access to highly active antiretroviral therapy (HAART) since November 1996. Although secondary data based on official mortality statistics indicate a sharp decrease in AIDS mortality, few if any studies tried to estimate the prognosis for patients with HIV who have been followed from the beginning of the HAART era. An observational study, with retrospective and prospective components, was done in 233 adult HIV-1-infected subjects who were recruited in the last 10 years at the outpatient sector of the Secondary Immunodeficiencies Clinic of the Department of Dermatology, Hospital das Clinicas da FMUSP, Sao Paulo, Brazil. The definition of AIDS followed the guidelines issued by the Centers for Disease Control (CDC) in 1987. One hundred sixty patients were asymptomatic, 46 had AIDS, 24 had AIDS-related complex, and 3 presented with acute infection at study entry. Twenty-nine (18%) of the asymptomatic subjects developed AIDS during follow-up, with 5 (3%) deaths. Among the 46 AIDS cases at entry, 7 (17%) died during follow-up. Thus, a total of 12 people (5.2%) died of AIDS in this cohort over a mean follow-up of 5.2 years and 24 people were lost to follow-up (10.3%). Ninety percent of the survivors were on combined therapy (82% with 3 or more drugs, and 8% with 2 drugs), while 10% were not taking antiretrovirals. People with AIDS at entry were 5 times more likely to die during this period compared to patients who were asymptomatic at entry (p = 0.006). Women showed better outcomes than men, reflecting differences in CD4+ T-cell counts at study entry. All but 1 patient progressed to AIDS during the pre-HAART era (before 1996). In spite of its recent decline, mortality from AIDS-related conditions remains an important public health issue.

29 September 2023 in LWT
Verified
Journal Article
Open access
LLLeonardo Lopes-Luz
Leonardo Lopes-Luz
MMMarcelo Mendonça
Marcelo Mendonça
MFMatheus Bernardes Torres Fogaça
Matheus Bernardes Torres Fogaça
DSDjairo Saavedra
Djairo Saavedra
BBBrenda Garcia Bentivoglio-Silva
Brenda Garcia Bentivoglio-Silva
SBSamira Bührer-Sékula
Samira Bührer-Sékula

3 August 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
FMFelipe Pereira de Melo
Felipe Pereira de Melo
PSPriscila Oliveira da Silva
Priscila Oliveira da Silva
SCSaruanna Millena dos Santos Clemente
Saruanna Millena dos Santos Clemente
RMRenata Pimentel Bandeira de Melo
Renata Pimentel Bandeira de Melo
JSJosé Givanildo da Silva
José Givanildo da Silva
MBMércia Rodrigues Barros
Mércia Rodrigues Barros
In this study, we evaluated the prevalence of Campylobacter jejuni, Campylobcater coli, and virulence genes in fresh, chilled, and frozen chicken carcasses with livers and gizzards sold in public markets and supermarkets. Of the 90 samples analyzed, C. jejuni was the most prevalent, with 28.8% of positive samples, whereas C. coli was positive in 15.6% of samples. In public market samples, C. coli had a higher prevalence than C. jejuni, with 16.7% positive samples detected, whereas in supermarket samples, C. jejuni was more prevalent (36.7% positivity). C. jejuni was detected in all forms of commercialized carcasses; however, there was a higher prevalence (43.3%) in chilled samples than C. coli, which was not detected in frozen samples but showed a higher prevalence (16.7%) in fresh samples. Both species were detected in different poultry products, with C. jejuni being more prevalent (53.3%) in liver samples. C. coli showed a higher prevalence in samples of meat pieces (10%). The presence of five virulence genes related to adherence (Peb1, JlpA, CadF, and CapA) and invasion (CiaB) was also observed in both species.